Curofy
Rivaroxaban Prevents VTE in GI Cancer Patients
Rivaroxaban prevents venous thromboembolism (VTE) in patients with gastrointestinal cancer who are undergoing chemotherapy, but physicians need to be mindful of bleeding in these at-risk patients.
See this content immediately after install